All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS ...

Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...

Before the pandemic, Moderna was a small, obscure outfit. In 2019, it was dependent on government agencies, non-profits, and ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...

CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the ...

The approval keeps Moderna on track to deliver doses ahead of the 2025-2026 vaccination season. Production will take place in ...

All pre-filled syringe doses for the Canadian market will be manufactured domestically for the first time, with drug ...

Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports from Newsweek and The Daily Beast that the Trump administration may be ...

The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult decision but necessary step forward,” in an internal memo sent to employees on ...

An update to Moderna's COVID-19 vaccine that targets the newest variants and is made entirely within Canada's borders was just approved by Health Canada.

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the ...